Current Cancer Drug Targets

Aims & Scope

Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but not limited to cellular and molecular biology, genomics, proteomics, metabolomics, medicinal chemistry, pharmacology, toxicology, and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters/commentary/perspectives, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel drug targets for human anticancer drug discovery continues to grow, this journal has become essential reading for all biomedical and pharmaceutical scientists involved in drug discovery and development.

Its scope covers publications related to prevention, diagnosis and treatment of all types of human cancers in various of basic and translational researches, including cancer etiology, signal transduction, biomarker, chemotherapy, hormone therapy, gene therapy, immunotherapy, radiotherapy, immunotherapy and combination therapy, stem cell, tumor environment, metabolism emphasizing on advanced mechanistic investigations.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	2.30

Journal Rank

Year	Value
2024	7800

Journal Citation Indicator

Year	Value
2024	592

SJR (SCImago Journal Rank)

Year	Value
2024	0.722

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	106

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

  Citation: 909

  Authors: Yong, Ranxin, Xia, Han-Ming

• The Role of Snail in EMT and Tumorigenesis

  Citation: 719

  Authors: Yifan, Jian, Kequn, Xuhua, Binhua

• The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

  Citation: 691

  Authors: Amancio, Carmen, Oliver, Wolfgang, Juan

• Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

  Citation: 671

  Authors: D., M., S., J., Q.

• Oxidative Stress and Cancer: The Role of Nrf2

  Citation: 346

  Authors: Soraya, Mozafar

• P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives

  Citation: 334

  Authors: Ziyad, Afsaneh

• Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action

  Citation: 308

  Authors: M., J., I.

• Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

  Citation: 289

  Authors: R., Z., D., R., M.

• The Role of Fibroblast Growth Factors in Tumor Growth

  Citation: 287

  Authors: M., R.

• Garlic [Allium sativum]: A Review of its Potential Use as an Anti-Cancer Agent

  Citation: 279

  Authors: Martha, Muslim

---